Savyon Diagnostics develops, manufactures and markets high quality diagnostic kits for the detection of Infectious Diseases and other medical conditions for more than 35 years. One of Savyon's leading products was developed to allow targeted treatment for H. pylori infection, known as one of the most common bacterial infections worldwide with high antibiotic resistance to the current treatment.
Yael Mali
Company's Solutions
Antibiotic resistance in Helicobacter pylori (H. pylori) is a risk to human health
H.pylori is one of the most common bacterial Infections worldwide and is closely associated with chronic gastritis, peptic ulcers, and gastric cancer.
The extent of eradication failure is estimated to be as high as 30%. Eradication failure results mainly due to the bacteria resistance to the recommended antibiotic treatment regimen
Savvygen H. pylori & Antibiotic Resistance kit is a First Line Screening RT-PCR Assay for H. pylori and it's resistance to Clarithromycin from Stool Specimens.
- Non-Invasive test, minimizes patient discomfort
- Allows for optimal antibiotic treatment and for better management of H. pylori
- Reduces misuse of antibiotics
Prominent Case Study
Current management of H. pylori is based on a unified first line antibiotic treatment followed by second, and third-line treatment in case of eradication failure.
The sensitivity and specificity of Savyon's test is 98% and 100% respectively according to clinical evaluations performed with samples collected from H. pylori symptomatic patients, therefore using the test as First Line Screening reduces the regimen of trial and error to eradicate the bacteria, thereby reducing costs of H.pylori management.